(Q39320412)

English

Novel 12-membered non-antibiotic macrolides, EM900 series with anti-inflammatory and/or immunomodulatory activity; synthesis, structure-activity relationships and in vivo study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Novel 12-membered non-antibiotic macrolides, EM900 series with anti-inflammatory and/or immunomodulatory activity; synthesis, structure-activity relationships and in vivo study (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

0 references

Akihiro Sugawara

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

6

object named as

Satoshi Omura

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

author name string

Akito Sueki

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Tomoyasu Hirose

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Hideaki Shima

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Kiyoko S Akagawa

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Toshiaki Sunazuka

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

4 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

The Journal of Antibiotics

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

487-490

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Motilides, macrolides with gastrointestinal motor stimulating activity. I. O-substituted and tertiary N-substituted derivatives of 8,9-anhydroerythromycin A 6,9-hemiacetal

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.51

21 January 2018

Therapy with macrolides in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.51

21 January 2018

Anti-inflammatory effects of macrolide antibiotics

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.51

21 January 2018

Gastrointestinal motor-stimulating activity of macrolide antibiotics and the structure-activity relationship

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.51

7 January 2021

based on heuristic

inferred from DOI database lookup

Macrolides with gastrointestinal motor stimulating activity

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.51

7 January 2021

based on heuristic

inferred from DOI database lookup

Motilides, macrolides with gastrointestinal motor stimulating activity. II. Quaternary N-substituted derivatives of 8,9-anhydroerythromycin A 6,9-hemiacetal and 9,9-dihydroerythromycin A 6,9-epoxide

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.51

7 January 2021

based on heuristic

inferred from DOI database lookup

Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.51

7 January 2021

based on heuristic

inferred from DOI database lookup

Erythromycin promotes monocyte to macrophage differentiation

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.51

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological effects of macrolides

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.51

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.51

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.51

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/JA.2012.51

1 reference

https://api.fatcat.wiki/v0/release/xtewgwxp4jcyra4qt54gdnneuy

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_xtewgwxp4jcyra4qt54gdnneuy

1 reference

https://api.fatcat.wiki/v0/release/xtewgwxp4jcyra4qt54gdnneuy

30 July 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

https://api.fatcat.wiki/v0/release/xtewgwxp4jcyra4qt54gdnneuy

30 July 2022

based on heuristic

mapped directly with Wikidata item

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39320412&oldid=2202777754"